pharmaceutical product development

1 similar search for pharmaceutical product development

Pharmaceutical Product Development, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

More than 10.000 documents for pharmaceutical product development

- Rrd Selected As Development Partner for Nih Therapeutics for Rare and Neglected Diseases Program
ROCKVILLE, Md., Jan. 24, 2011 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that it has entered into a partnership with the National Institutes of Health (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program as a regulatory support and development partner. The RRD and TRND partnership will focus on two rare disease drug development projects: Hereditary Inclusion Body Myopathy (HIBM), a rare adult-onset neuromuscular disorder and Niemann Pick type C1 Disease (NPC1), a rare neurodegenerative genetic disease.
- U.S. Newswire
- January 24, 2011
- Research and Markets: Pharmaceutical Product Development Inc - Therapeutic Competitors.
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dc413f/pharmaceutical_pro) has announced the addition of the "Pharmaceutica...
- Business Wire
- June 21, 2010
- Law Offices of Howard G. Smith LLP Continues Investigation of Pharmaceutical Product Development, Inc.
LOS ANGELES -- Law Offices of Howard G. Smithis continuing its investigation of potential claims against the Board of Directors of Pharmaceutical Prod...
- Business Wire
- October 07, 2011

- Pharmaceutical Product Development.
WILMINGTON -- Pharmaceutical Product Development, which conducts clinical research for drug companies, plans to acquire Russian competitor InnoPharm. ...
- Business North Carolina
- Vol. 28 Nbr. 4, April 2008
- Mintz Levin Attorney works on international deal: San Diego-based attorney Jeremy Glaser, who practices corporate law at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo RC., recently represented contract research organization BioDuro LLC in its acquisition by Pharmaceutical Product Development Inc.
Mintz Levin Attorney Works On International Deal: San Diego-based attorney Jeremy Glaser, who practices corporate law at Mintz, Levin, Cohn, Ferris, G...
- San Diego Business Journal
- January 25, 2010
- S&P Indices Announces Changes to U.S. Indices
NEW YORK, Dec. 5, 2011 /PRNewswire/ -- S&P SmallCap 600 constituent National Retail Properties Inc. (NYSE: NNN) will replace Pharmaceutical Product Development Inc. (NASD: PPDI) in the S&P MidCap 400 index, and Higher One Holdings Inc. (NYSE: ONE) will replace National Retail Properties in the S&P SmallCap 600 index after the close of trading on Wednesday, December 7. Pharmaceutical Product Development is being acquired by affiliates of The Carlyle Group and Hellman & Friedman in a deal that closed today. S&P Indices will post any relevant updates on its website: www.standardandpoors.com.
- U.S. Newswire
- December 06, 2011
- Schaeffer's Daily Market Blog Features MicroStrategy, Comerica, Pharmaceutical Product Development, General Motors, and Reynolds American.
CINCINNATI -- Among the stocks featured in the July 14 edition of Schaeffer's Market Blog are MicroStrategy (NASDAQ:MSTR), Comerica (NYSE:CMA), Pharma...
- Business Wire
- July 14, 2005
- Schaeffer's Daily Market Blog Features Panera Bread Company, 3M Company, Pharmaceutical Product Development, Exxon Mobil, and Guidant.
CINCINNATI -- Among the stocks featured in the October 18 edition of Schaeffer's Market Blog are Panera Bread Company (NASDAQ:PNRA), 3M Company (NYSE:...
- Business Wire
- October 18, 2005
- Zacks.com featured expert Kevin Matras highlights: AGCO, Humana and Pharmaceutical Product Development.
CHICAGO -- Kevin Matras outlines one of the screens he's been using in today's tough market. Stocks in this week's article are AGCO Corporation (NYSE:...
- Business Wire
- January 09, 2008
- Pharmaceutical Product Development.
WILMINGTON -- Fred Davenport, 54, resigned as president of Pharmaceutical Product Development, saying he wanted to spend more time with his family. He...
- Business North Carolina
- Vol. 26 Nbr. 12, December 2006